GlassScriptPhysician profile
David M Brill
NPI 1164483822
$2,009.75
in general payments reported to CMS, 2019-2025
29 companies · $28.63 in 2025
The $28.63 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $731 · 2020: $91.57 · 2021: $265 · 2022: $164 · 2023: $464 · 2024: $266 · 2025: $28.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $759.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $759.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $371.05 | 2019 | |
| Novartis Pharmaceuticals Corporation | $296.60 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $195.03 | 2021-2023 | Xarelto |
| Edwards Lifesciences Corporation | $182.93 | 2019-2024 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Boston Scientific Corporation | $165.35 | 2023-2024 | Watchman Access System |
| Medtronic Vascular, INC. | $84.04 | 2019 | |
| Amgen INC. | $63.00 | 2019-2022 | |
| Esperion Therapeutics, INC. | $56.11 | 2020-2024 | Nexletol |
| Merck Sharp & Dohme LLC | $50.82 | 2021-2022 | |
| Atricure, INC. | $47.86 | 2024 | |
| Pfizer INC. | $43.94 | 2019-2024 | |
| Cardiovascular Systems INC. | $38.96 | 2019 | |
| Penumbra, INC. | $34.26 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $33.70 | 2023 | Arcalyst |
| Cook Medical LLC | $33.23 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $30.78 | 2022-2023 | Eliquis |
| W. L. Gore & Associates, INC. | $30.05 | 2019 | |
| Immunitybio, INC. | $28.63 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $24.44 | 2023 | Inpefa |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $23.50 | 2022 | |
| Novo Nordisk INC | $23.12 | 2023 | Ozempic, Rybelsus |
| Philips North America LLC | $22.59 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.01 | 2021 | |
| Vital Connect, INC | $20.95 | 2023 | Vitalpatch Rtm |
| Kestra Medical Technology Services, INC. | $20.45 | 2024 | Assure Wcd |
| Shockwave Medical, INC | $18.90 | 2019 | |
| Silk Road Medical, INC. | $17.59 | 2019 | |
| Stryker Corporation | $15.01 | 2021 | |
| Bardy Diagnostics, INC. | $14.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Brill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.